日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Real-World Characterization and Treatment Patterns of Patients with Desmoid Tumors at an Academic Center in the United States

美国某学术中心纤维瘤患者的真实世界特征及治疗模式

期刊:Cancer Research Communications
影响因子:3.3
doi:10.1158/2767-9764.CRC-25-0581
Tan, Chia Jie; Willis, Connor; Bell, Timothy; Tumminello, Brad; Zhou, Shengfan; Doshi, Dipam; Asche, Carl V; Biskupiak, Joseph; Brixner, Diana; Chalmers, Anna; Stenehjem, David D
发表日期：2026
文献求助 收藏

The changing epidemiology of adult liver transplantation in the United States in 2013-2022: The dominance of metabolic dysfunction-associated steatotic liver disease and alcohol-associated liver disease

2013-2022年美国成人肝移植流行病学的变化：代谢功能障碍相关性脂肪肝和酒精相关性肝病的主导地位

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000352
Younossi, Zobair M; Stepanova, Maria; Al Shabeeb, Reem; Eberly, Katherine E; Shah, Dipam; Nguyen, Veronica; Ong, Janus; Henry, Linda; Alqahtani, Saleh A
脂肪肝
代谢
发表日期：2024
文献求助 收藏

Two predators, one prey model that integrates the effect of supplementary food resources due to one predator's kleptoparasitism under the possibility of retribution by the other predator

两个捕食者，一个猎物模型，该模型整合了由于一个捕食者盗食寄生行为而产生的额外食物资源的影响，以及另一个捕食者可能进行的报复。

期刊:Heliyon
影响因子:3.6
doi:10.1016/j.heliyon.2024.e28940
Bhattacharjee, Debasish; Das, Dipam; Acharjee, Santanu; Dutta, Tarini Kumar
发表日期：2024
文献求助 收藏

Changes in mortality due to Chronic Liver Diseases (CLD) during the COVID-19 pandemic: Data from the United States' National Vital Statistics System

COVID-19 大流行期间慢性肝病 (CLD) 死亡率的变化：来自美国国家生命统计系统的数据

期刊:PLoS One
影响因子:2.6
doi:10.1371/journal.pone.0289202
Paik, James M; Shah, Dipam; Eberly, Katherine; Golabi, Pegah; Henry, Linda; Younossi, Zobair M
发表日期：2024
文献求助 收藏

Slow and Steady: A Slowly Progressing Neuroendocrine Tumor

缓慢而稳定：一种缓慢进展的神经内分泌肿瘤

期刊:
影响因子:
doi:10.14309/crj.0000000000001147
Zheng, Christie; Al Shabeeb, Reem; Shah, Dipam; Sardana, Nitin
肿瘤
肿瘤免疫
发表日期：2023
文献求助 收藏

ZYBT1, a potent, irreversible Bruton's Tyrosine Kinase (BTK) inhibitor that inhibits the C481S BTK with profound efficacy against arthritis and cancer

ZYBT1 是一种强效、不可逆的布鲁顿酪氨酸激酶 (BTK) 抑制剂，可抑制 C481S BTK，对关节炎和癌症具有显著疗效

期刊:Pharmacology Research & Perspectives
影响因子:2.9
doi:10.1002/prp2.565
Krishnarup Ghoshdastidar, Hoshang Patel, Hitesh Bhayani, Ankit Patel, Kinjal Thakkar, Dinesh Patel, Manoranjan Sharma, Jaideep Singh, Jogeswar Mohapatra, Abhijit Chatterjee, Dipam Patel, Rajesh Bahekar, Rajiv Sharma, Lakshmikant Gupta, Nirmal Patel, Poonam Giri, Nuggehally R Srinivas, Mukul Jain, De
免疫
关节炎
发表日期：2020
文献求助 收藏

Navigating Through the Financial Crisis that may Occur during and after the COVID-19 Pandemic for Gastroenterologists

胃肠病学家如何应对新冠疫情期间及之后可能出现的财务危机

期刊:Journal of Digestive Endoscopy
影响因子:1.1
doi:10.1055/s-0040-1712345
Patel, Dipam A; Shah, Chirag Narendrakumar
微生物学
新冠
发表日期：2020
文献求助 收藏